6ucx
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==S2 symmetric peptide design number 1, Wednesday== | |
- | + | <StructureSection load='6ucx' size='340' side='right'caption='[[6ucx]], [[Resolution|resolution]] 0.85Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UCX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6UCX FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 0.85Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DGL:D-GLUTAMIC+ACID'>DGL</scene>, <scene name='pdbligand=DLY:D-LYSINE'>DLY</scene>, <scene name='pdbligand=DPR:D-PROLINE'>DPR</scene>, <scene name='pdbligand=DVA:D-VALINE'>DVA</scene>, <scene name='pdbligand=TFA:TRIFLUOROACETIC+ACID'>TFA</scene></td></tr> |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6ucx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ucx OCA], [https://pdbe.org/6ucx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6ucx RCSB], [https://www.ebi.ac.uk/pdbsum/6ucx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6ucx ProSAT]</span></td></tr> |
- | [[Category: | + | </table> |
- | [[Category: | + | __TOC__ |
- | [[Category: Mulligan | + | </StructureSection> |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Antselovich I]] |
+ | [[Category: Baker D]] | ||
+ | [[Category: Kang CS]] | ||
+ | [[Category: Mulligan VK]] | ||
+ | [[Category: Sawaya MR]] | ||
+ | [[Category: Yeates TO]] |
Current revision
S2 symmetric peptide design number 1, Wednesday
|